Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties

Journal of Orthopaedic Research

Volumn 22, Issue 3, 2004, Pages 465-471

  Day, J S ^a   Ding, M ^b   Bednarz, P ^a,c   van der Linden, J C ^a   Mashiba, T ^d   Hirano, T ^d   Johnston, C C ^d   Burr, D B ^d   Hvid, I ^b   Sumner, D R ^e   Weinans, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c INSTITUTE OF FUNDAMENTAL TECHNOLOGICAL RESEARCH   (Poland)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

Author keywords

Bisphosphonates; Bone matrix mineralization; Bone micro architecture; Mechanical properties; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE INJURY; BONE MASS; BONE MATRIX; BONE MINERALIZATION; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOG; FEMALE; FINITE ELEMENT ANALYSIS; FRACTURE; HYPOTHESIS; LUMBAR VERTEBRA; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TRABECULAR BONE; YOUNG MODULUS;

ALENDRONATE; ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; DOGS; ETIDRONIC ACID; FEMALE;

EID: 11144353705     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orthres.2003.05.001     Document Type: Article

References (44)

1. Balena R. Toolan B.C. Shea M. Markatos A. Myers E.R. Lee S.C. et al. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates J. Clin. Invest. 92 1993 2577-2586
2. Black D.M. Cummings S.R. Karpf D.B. Cauley J.A. Thompson D.E. Nevitt M.C. et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Fracture Intervention Trial Research Group Lancet 348 1996 1535-1541
3. Boivin G.Y. Chavassieux P.M. Santora A.C. Yates J. Meunier P.J. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women Bone 27 2000 687-694
4. Burr D.B. Martin R.B. Schaffler M.B. Radin E.L. Bone remodelling in response to in vivo fatigue microdamage J. Biomech. 18 1985 189-200
5. Burr D.B. Turner C.H. Naick P. Forwood M.R. Ambrosius W. Hasan M.S. et al. Does microdamage accumulation affect the mechanical properties of bone? J. Biomech. 31 1998 337-345
6. Chavassieux P.M. Arlot M.E. Reda C. Wei L. Yates A.J. Meunier P.J. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodelling in patients with osteoporosis J. Clin. Invest. 100 1997 1475-1480
7. Crandall C. Risedronate: a clinical review Arch. Intern. Med. 161 2001 353-360
8. Currey J.D. Effects of differences in mineralization on the mechanical properties of bone Philos. Trans. R. Soc. Lond. B. Biol. Sci. 304 1984 509-518
9. Day J.S. Ding M. van der Linden J.C. Hvid I. Sumner D.R. Weinans H. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage J. Orthop. Res. 19 2001 914-918
10. Delmas P.D. How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone 27 2000 1-3
11. Ding M. Day J.S. Burr D.B. Mashiba T. Hirano T. Weinans H. et al. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates Calcif. Tissue Int. 72 2003 737-744
12. Ding M. Odgaard A. Hvid I. Accuracy of cancellous bone volume fraction measured by micro-CT scanning J. Biomech. 32 1999 323-326
13. Eventov I. Frisch B. Cohen Z. Hammel I. Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: a prospective study of 102 cases of femoral neck fractures Bone 12 1991 1-6
14. Harris S.T. Watts N.B. Genant H.K. McKeever C.D. Hangartner T. Keller M. et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial Vertebral Efficacy With Risedronate Therapy (VERT) Study Group Jama 282 1999 1344-1352
15. Heaney R.P. The bone-remodelling transient: implications for the interpretation of clinical studies of bone mass change J. Bone Miner. Res. 9 1994 1515-1523
16. Hirano T. Turner C.H. Forwood M.R. Johnston C.C. Burr D.B. Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation? Bone 27 2000 13-20
17. Jacobs C.R. Davis B.R. Rieger C.J. Francis J.J. Saad M. Fyhrie D.P. NACOB presentation to ASB Young Scientist Award: Postdoctoral. The impact of boundary conditions and mesh size on the accuracy of cancellous bone tissue modulus determination using large-scale finite-element modeling North American Congress on Biomechanics J. Biomech. 32 1999 1159-1164
18. Kabel J. van Rietbergen B. Dalstra M. Odgaard A. Huiskes R. The role of an effective isotropic tissue modulus in the elastic properties of cancellous bone J. Biomech. 32 1999 673-680
19. Keaveny T.M. Pinilla T.P. Crawford R.P. Kopperdahl D.L. Lou A. Systematic and random errors in compression testing of trabecular bone J. Orthop. Res. 15 1997 101-110
20. Kuhn J.L. Goldstein S.A. Feldkamp L.A. Goulet R.W. Jesion G. Evaluation of a microcomputed tomography system to study trabecular bone structure J. Orthop. Res. 8 1990 833-842
21. Ladd A.J. Kinney J.H. Numerical errors and uncertainties in finite-element modeling of trabecular bone J. Biomech. 31 1998 941-945
22. Ladd A.J. Kinney J.H. Haupt D.L. Goldstein S.A. Finite-element modeling of trabecular bone: comparison with mechanical testing and determination of tissue modulus J. Orthop. Res. 16 1998 622-628
23. Linde F. Hvid I. The effect of constraint on the mechanical behaviour of trabecular bone specimens J. Biomech. 22 1989 485-490
24. Mashiba T. Hirano T. Turner C.H. Forwood M.R. Johnston C.C. Burr D.B. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib J. Bone Miner. Res. 15 2000 613-620
25. Mashiba T. Turner C.H. Hirano T. Forwood M.R. Johnston C.C. Burr D.B. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 2001 524-531
26. McClung M.R. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis Bone 19 1996 195S-198S
27. Meunier P.J. Boivin G. Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications Bone 21 1997 373-377
28. Monier-Faugere M.C. Geng Z. Paschalis E.P. Qi Q. Arnala I. Bauss F. et al. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties J. Bone Miner. Res. 14 1999 1768-1778
29. Mori S. Burr D.B. Increased intracortical remodelling following fatigue damage Bone 14 1993 103-109
30. Niebur G.L. Yuen J.C. Hsia A.C. Keaveny T.M. Convergence behavior of high-resolution finite element models of trabecular bone J. Biomech. Eng. 121 1999 629-635
31. Parfitt A.M. The composition, structure and remodelling of bone: a basis for interpretation of bone mineral measurements, in: Dequeker J. Geusens P. Wahner H.W. (Eds.), Bone mineral measurement by photon absorptiometry 1988 Leuven University Press Leuven
32. Rho J.Y. Roy II M.E. Tsui T.Y. Pharr G.M. Elastic properties of microstructural components of human bone tissue as measured by nanoindentation J. Biomed. Mater. Res. 45 1999 48-54
33. Rodan G.A. Fleisch H.A. Bisphosphonates: mechanisms of action J. Clin. Invest. 97 1996 2692-2696
34. Roschger P. Fratzl P. Klaushofer K. Rodan G. Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs Bone 20 1997 393-397
35. Russell R.G. Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again Bone 25 1999 97-106
36. Siris E. Alendronate in the treatment of osteoporosis: a review of the clinical trials J. Womens Health Gend. Based Med. 9 2000 599-606
37. Tonino R.P. Meunier P.J. Emkey R. Rodriguez-Portales J.A. Menkes C.J. Wasnich R.D. et al. Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III osteoporosis treatment study group J. Clin. Endocrinol. Metab. 85 2000 3109-3115
38. Ulrich D. Hildebrand T. Van Rietbergen B. Muller R. Ruegsegger P. The quality of trabecular bone evaluated with micro-computed tomography, FEA and mechanical testing Stud. Health Technol. Inform. 40 1997 97-112
39. Ulrich D. van Rietbergen B. Weinans H. Ruegsegger P. Finite element analysis of trabecular bone structure: a comparison of image-based meshing techniques J. Biomech. 31 1998 1187-1192
40. Van Der Linden J.C. Birkenhager-Frenkel D.H. Verhaar J.A. Weinans H. Trabecular bone's mechanical properties are affected by its nonuniform mineral distribution J. Biomech. 34 2001 1573-1580
41. van Rietbergen B. Weinans H. Huiskes R. Odgaard A. A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models J. Biomech. 28 1995 69-81
42. Verborgt O. Gibson G.J. Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodelling after fatigue in vivo J. Bone Miner. Res. 15 2000 60-67
43. Weinstein R.S. True strength J. Bone Miner. Res. 15 2000 621-625
44. Zioupos P. Accumulation of in vivo fatigue microdamage and its relation to biomechanical properties in ageing human cortical bone J. Microsc. 201 2001 270-278